Introduction {#Sec1}
============

About 30 species of *Clausena* (Rutaceae) are widely distributed in the world, and 10 of them exist in China. *Clausena lansium* (Lour.) Skeels is a fruit tree and distributes widely in south of China \[[@CR1]\]. Its leaves and roots have been used as a folk herb for the treatment of cough, asthma, dermatological disease, viral hepatitis, and gastro-intestinal disease; and its seeds for treating acute and chronic gastrointestinal inflammation, and ulcer \[[@CR2]\]. Caryophyllaceae-type cyclopeptides (CPs), carbazole alkaloids, coumarins, amides, and terpenoids have been isolated from *C. lansium* \[[@CR3]--[@CR8]\]. Among them, CPs are formed with the peptide bonds of protein or non-proten α-amino acid residues, which are homomonocyclopeptides with mainly five to twelve α-amino acid residues \[[@CR9]\]. During this work, two new cyclic nonapeptides, named clausenlanins A (**1**) and B (**2**) (Fig. [1](#Fig1){ref-type="fig"}), were isolated from the roots and rhizomes of *C. lansium*. Because the ^1^H NMR signals are weak and severely overlapped taken at room temperature, variable temperature NMR experiments were performed \[[@CR10]\]. In this paper, their separation and structure elucidation are described.Fig. 1Structures of compounds **1** and **2** from *C. lansium*

Results and Discussion {#Sec2}
======================

Clausenlanin A (**1**) was obtained as an amorphous solid. Its molecular formula was shown as C~50~H~91~N~9~O~9~ by its negative HRESIMS (\[M−H\]^−^, 960.6876, calcd 960.6867), indicating the 10° of unsaturation. The IR spectrum exhibited the absorption bands at 3429 and 1661 cm^--1^ ascribable to NH and CO groups. The ^1^H and ^13^C NMR spectra of **1** in C~5~D~5~N (Table [1](#Tab1){ref-type="table"}) displayed the characteristic signals of typical CPs.Table 1NMR data of compounds **1** and **21**\***2** ^\#^ResiduePosition*δ* ~H~*δ* ~C~ResiduePosition*δ* ~H~*δ* ~C~Gly-1α4.51 (d, 5.1)44.8 (t)Gly-1α4.57 (overlap)44.6 (t)3.85 (dd, 5.1, 16.3)3.91 (dd, 5.2, 16.4)NH8.75 (overlap)NH9.03 (br.s)C=O171.1 (s)C=O171.2 (s)Leu-2α4.77 (d, 7.0)53.7 (d)Leu-2α4.87 (br.s)53.3 (d)β1.93--2.21 (overlap)40.6 (t)β1.93 (overlap)40.4 (t)^a^2.07 (overlap)γ1.87--1.99 (overlap)25.8 (d)^a^γ1.89--2.00 (overlap)25.8 (d)^b^δ0.93--1.06 (overlap)23.7 (q)^b^δ0.86--1.03 (overlap)23.4 (q)^c^0.91--1.02 (overlap)22.3 (q)^c^0.86--1.03 (overlap)22.0 (q)^d^NH8.23 (d, 7.0)NH8.42 (br.s)C=O175.6 (s)C=O174.7 (s)^e^Ile-3α4.46 (overlap)61.2 (d)Val-3α4.42 (br.s)62.6 (d)β2.30 (overlap)36.7 (d)β2.57 (m)30.6 (d)γ1.39 (m)26.7 (t)γ1.18 (d, 4.4)20.3 (q)1.87 (overlap)1.19 (d, 4.4)20.2 (q)Me γ1.18 (d, 6.7)16.6 (q)Me δ0.92 (overlap)11.5 (q)NH8.72 (overlap)NH9.22 (overlap)C=O173.9 (s)C=O173.9 (s)Leu-4α4.58 (overlap)54.5 (d)Leu-4α4.65 (overlap)54.6 (d)β1.93--2.21 (overlap)40.0 (t)^d^β2.07 (overlap)39.9 (t)^a^γ1.87--1.99 (overlap)25.9 (d)^a^γ1.89--2.00 (overlap)25.7 (d)^b^δ0.93--1.06 (overlap)23.6 (q)^b^δ0.86--1.03 (overlap)23.6 (q)^c^0.91--1.02 (overlap)22.3 (q)^c^0.86--1.03 (overlap)22.0 (q)^d^NH8.73 (overlap)NH9.23 (overlap)C=O173.5 (s)C=O173.8 (s)^e^Leu-5α4.81 (d, 7.2)54.0 (d)Leu-5α4.93 (br.s)53.7 (d)β1.93--2.21 (overlap)40.6 (t)β2.17 (overlap)40.4 (t)^a^2.31 (overlap)γ1.87--1.99 (overlap)25.5 (d)^a^γ1.89--2.00 (overlap)25.6 (d)^b^δ0.93--1.06 (overlap)23.8 (q)^b^δ0.86--1.03 (overlap)23.8 (q)^c^0.91--1.02 (overlap)22.6 (q)^c^0.86--1.03 (overlap)22.4 (q)^d^NH8.10 (d, 7.2)NH8.35 (br.s)C=O174.4 (s)C=O174.7 (s)^e^Leu-6α4.59 (overlap)54.8 (d)Leu-6α4.66 (overlap)54.5 (d)β1.93--2.21 (overlap)40.3 (t)^d^β2.07 (overlap)39.8 (t)^a^2.28 (overlap)γ1.87--1.99 (overlap)25.8 (d)^a^γ1.89--2.00 (overlap)25.2 (d)^b^δ0.93--1.06 (overlap)23.7 (q)^b^δ0.86--1.03 (overlap)23.4 (q)^c^0.91--1.02 (overlap)22.3 (q)^c^0.86--1.03 (overlap)22.0 (q)^d^NH8.52 (d, 6.3)NH8.85 (br.s)C=O174.1 (s)C=O174.1 (s)^e^Leu-7α4.46 (overlap)54.9 (d)Leu-7α4.50 (br.s)54.7 (d)β1.93--2.21 (overlap)40.1 (t)β2.28 (overlap)39.7 (t)^a^2.36 (br.s)γ1.87--1.99 (overlap)26.0 (d)^a^γ1.89--2.00 (overlap)25.7 (d)^b^δ0.93--1.06 (overlap)23.5 (q)^b^δ0.86--1.03 (overlap)23.7 (q)^c^0.91--1.02 (overlap)22.1 (q)^c^0.86--1.03 (overlap)21.8 (q)^d^NH8.46 (d, 6.2)NH8.76 (br.s)C = O174.7 (s)C = O175.7 (s)^e^Leu-8α4.68 (dd, 6.3, 7.9)54.7 (d)Leu-8α4.79 (br.s)54.1 (d)β1.93--2.21 (overlap)40.3 (t)β2.07 (overlap)40.0 (t)^a^2.19 (overlap)γ1.87--1.99 (overlap)25.8 (d)^a^γ1.89--2.00 (overlap)25.6 (d)^b^δ0.93--1.06 (overlap)23.7 (q)^b^δ0.86--1.03 (overlap)23.7 (q)^c^0.91--1.02 (overlap)22.3 (q)^c^0.86--1.03 (overlap)22.0 (q)^d^NH8.36 (d, 6.3)NH8.61 (br.s)C=O174.5 (s)C=O174.6 (s)^e^Leu-9α4.57 (overlap)53.6 (d)Leu-9α4.56 (overlap)53.6 (d)β1.93--2.21 (overlap)40.1 (t)^d^β2.17 (overlap)40.4 (t)^a^2.28 (overlap)γ1.87--1.99 (overlap)25.9 (d)^a^γ1.89--2.00 (overlap)25.7 (d)^b^δ0.93--1.06 (overlap)23.5 (q)^b^δ0.86--1.03 (overlap)23.8 (q)^c^0.91--1.02 (overlap)22.2 (q)^c^0.86--1.03 (overlap)22.0 (q)^d^NH8.91 (br.s)NH9.38 (overlap)C=O173.9 (s)C=O173.5 (s)^e^J values given in Hz in parentheses^a,\ b,\ c,\ d,\ e^ Chemical shifts can be exchanged with each other in the column\* In C~5~D~5~N, 338 K, 400 MHz for ^1^H and 100 MHz for ^13^C^\#^In C~5~D~5~N, 303 K, 800 MHz for ^1^H and 200 MHz for ^13^C

The ^1^H NMR signals of the amino acid residues of **1**, especially the signals of NH and α-H, were severely overlapped taken at room temperature. The significant improvement of the ^1^H NMR signals was observed by increasing the temperatures from 243 to 338 K. Finally a well-resolved ^1^H NMR spectrum with sharp proton signals (Fig. [2](#Fig2){ref-type="fig"}a) was obtained at 338 K in pyridine-d~5~. Then the assignment of the ^1^H NMR signals of the amino acid residues was obtained by analyzing the ^1^H-^1^H COSY spectrum, particularly amide proton NH and α-H signals. The corresponding ^13^C NMR assignments were determined on the basis of the HSQC and HMBC experiments, particularly α-C signals (Table [1](#Tab1){ref-type="table"}). The ^1^H-NMR spectrum of **1** showed the presence of nine NH (*δ* ~H~ 8.91, 8.75, 8.73, 8.72, 8.52, 8.46, 8.36, 8.23, 8.10) and ten α-H (*δ* ~H~ 4.81, 4.77, 4.68, 4.59, 4.58, 4.57, 4.51, 4.46, 4.46, 3.85), respectively. The ^13^C-NMR spectrum of **1** displayed nine carbonyl CO signals at *δ* ~C~ 175.6, 174.7, 174.5, 174.4, 174.1, 173.9, 173.9, 173.5, 171.1, eight α-CH signals at *δ* ~C~ 61.2, 54.9, 54.8, 54.7, 54.5, 54.0, 53.7, 53.6, one α-CH~2~ signal at *δ* ~C~ 44.8. These data indicated that **1** might be a cyclic nonapeptide. Analysis of the HSQC, HMBC and COSY spectra revealed that **1** consisted of one glycine (*δ* ~H~ 4.51 and 3.85 (α-H~2~), 8.75 (NH); *δ* ~C~ 171.1 (CO), 44.8 (α-CH~2~)), and one isoleucine (*δ* ~H~ 4.46 (α-CH), 2.30 (β-CH), 1.39 and 1.87 (γ-CH~2~), 1.18 (γ-CH~3~), 0.92 (δ-CH~3~), 8.72 (NH); *δ* ~C~ 173.9 (CO), 61.2 (α-CH), 36.7 (β-CH), 26.7 (γ-CH~2~), 16.6 (γ-CH~3~), 11.5 (δ-CH~3~)). The remaining signals mentioned-above of seven NH and seven α-H signals, seven CO and seven α-C signals, and other signals including seven methylenes at *δ* ~C~ 40.0--40.6, seven methines at *δ* ~C~ 25.5--26.0, two kinds of fourteen methyls at *δ* ~C~ 23.5--23.8 and at *δ* ~C~ 22.1--22.6, indicated that **1** contained other seven leucines. Therefore **1** consisted of seven leucines, one glycine, and one isoleucine (Table [1](#Tab1){ref-type="table"}; Fig. [3](#Fig3){ref-type="fig"}).Fig. 2^1^H NMR of compounds **1** (**a**) and **2** (**b**) at different temperatures Fig. 3Key HMBC, ^1^H-^1^H COSY, and ROESY/NOESY correlations of **1** and **2**

The sequence of the nine amino acid residues in **1** was determined by analyzing the ROESY correlations between the α-H of one amino acid residue and the amide proton NH of the next amino acid residue (Fig. [3](#Fig3){ref-type="fig"}). The ROESY correlations of Gly^1^-αH/Leu^2^-NH, Leu^2^-αH/Ile^3^-NH, Ile^3^-αH/Leu^4^-NH, Leu^4^-αH/Leu^5^-NH, Leu^5^-αH/Leu^6^-NH, Leu^6^-αH/Leu^7^-NH, Leu^7^-αH/Lue^8^-NH, Leu^8^-αH/Leu^9^-NH, Leu^9^-αH/Gly^1^-NH indicated that the structure of **1** is cyclo-(Gly^1^-Leu^2^-Ile^3^-Leu^4^-Leu^5^-Leu^6^-Leu^7^-Leu^8^-Leu^9^). This sequence of **1** was confirmed by the fragment ion peaks at 962.96 \[M+H\]^+^, 849.83 \[M+H−113\]^+^, 736.72 \[M+H−2\*113\]^+^, 623.64 \[M+H−3\*113\]^+^, 510.52 \[M+H− 4\*113\]^+^, 453.49 \[M+H−4\*113−57\]^+^, 340.43 \[M+H−4\*113--57−113\]^+^, 227.29 \[M+H−4\*113--57−2\*113\]^+^ in the positive ESIMSMS.

The absolute configuration of the amino acids of **1** was determined using the advanced Marfey's method and LC--MS analysis \[[@CR11], [@CR12]\]. The results indicated that the absolute configurations of the amino acid residues (Leu and Ile) in **1** were the [l]{.smallcaps}-configuration (Table S1; Fig. [3](#Fig3){ref-type="fig"}). Therefore the structure of **1** is determined as cyclo-(Gly^1^-[l]{.smallcaps}-Leu^2^-[l]{.smallcaps}-Ile^3^-[l]{.smallcaps}-Leu^4^-[l]{.smallcaps}-Leu^5^-[l]{.smallcaps}-Leu^6^-[l]{.smallcaps}-Leu^7^-[l]{.smallcaps}-Leu^8^-[l]{.smallcaps}-Leu^9^).

Clausenlanin B (**2**) was obtained as an amorphous solid. Its molecular formula was shown as C~49~H~89~N~9~O~9~ by its negative HRESIMS (\[M−H\]^−^, 946.6723, calcd 946.6710), indicating the 10° of unsaturation. The IR spectrum exhibited the absorption bands at 3430 and 1661 cm^--1^ ascribable to NH and CO groups. The ^1^H and ^13^C NMR spectra of **2** in C~5~D~5~N (Table [1](#Tab1){ref-type="table"}) displayed the characteristic signals of typical CPs.

The ^1^H NMR signals of the amino acid residues of **2**, especially the signals of NH and α-H, were severely overlapped taken at room temperature. The significant improvement of the ^1^H NMR signals was observed by increasing the temperatures from 243 to 338 K. Finally a well-resolved ^1^H NMR spectrum with sharp proton signals (Fig. [2](#Fig2){ref-type="fig"}b) was obtained at 303 K in pyridine-d~5~. After compared all data of **2** with those of **1**, the results indicated that **2** and **1** are very similar, and **2** might also be a cyclic nonapeptide too. The only difference is to be replaced the isoleucine residue in **1** by valine residue in **2**. The assignment of the ^1^H and ^13^C NMR signals of the valine residue was obtained by analyzing the HSQC, HMBC and COSY spectra, i.e. *δ* ~H~ 4.42 (α-CH), 2.57 (β-CH), 1.18 and 1.19 (2\*γ-CH~3~), 9.22 (NH); *δ* ~C~ 173.9 (CO), 62.6 (α-CH), 30.6 (β-CH), 20.3 and 20.2 (2\*γ-CH~3~). Therefore **2** consisted of seven leucines, one glycine, and one valine (Table [1](#Tab1){ref-type="table"}; Fig. [3](#Fig3){ref-type="fig"}).

The sequence of the nine amino acid residues in **2** was determined by analyzing NOESY correlations between the α-H of one amino acid residue and the amide proton NH of the next amino acid residue (Fig. [3](#Fig3){ref-type="fig"}). The NOESY correlations of Gly^1^-αH/Leu^2^-NH, Leu^2^-αH/Val^3^-NH, Val^3^-αH/Leu^4^-NH, Leu^4^-αH/Leu^5^-NH, Leu^5^-αH/Leu^6^-NH, Leu^6^-αH/Leu^7^-NH, Leu^7^-αH/Lue^8^-NH, Leu^8^-αH/Leu^9^-NH, Leu^9^-αH/Gly^1^-NH indicated that the structure of **2** is cyclo-(Gly^1^-Leu^2^-Val^3^-Leu^4^-Leu^5^-Leu^6^-Leu^7^-Leu^8^-Leu^9^). This sequence of **2** was confirmed by the fragment ion peaks at 948.86 \[M+H\]^+^, 835.70 \[M+H−113\]^+^, 722.56 \[M+H−2\*113\]^+^, 609.54 \[M+H−3\*113\]^+^, 496.39 \[M+H−4\*113\]^+^, 383.41 \[M+H−5\*113\]^+^, 270.24 \[M+H−6\*113\]^+^ in the positive ESIMSMS.

The absolute configuration of **2** was determined using the advanced Marfey's method and LC--MS analysis too \[[@CR11], [@CR12]\]. The results indicated that the absolute configurations of the amino acid residues (Leu and Val) in **2** were the [l]{.smallcaps}-configuration (Table S1; Fig. [3](#Fig3){ref-type="fig"}). Therefore the structure of **2** is determined as cyclo-(Gly^1^-[l]{.smallcaps}-Leu^2^-[l]{.smallcaps}-Val^3^-[l]{.smallcaps}-Leu^4^-[l]{.smallcaps}-Leu^5^-[l]{.smallcaps}-Leu^6^-[l]{.smallcaps}-Leu^7^-[l]{.smallcaps}-Leu^8^-[l]{.smallcaps}-Leu^9^).

Experimental {#Sec3}
============

General Experimental Procedures {#Sec4}
-------------------------------

Optical rotations were obtained on a Jasco P-1020 polarimeter. IR spectra were measured on a Tensor 27 spectrometer with KBr pellets. UV spectra were obtained using a Shimadzu UV-2401PC spectrophotometer. 1D and 2D NMR spectra were performed on a Bruker AM-400 (^1^H: 400 MHz, ^13^C: 100 MHz) or Bruker AVANCE III-800 (^1^H: 800 MHz, ^13^C: 200 MHz). Chemical shifts were expressed in ppm with reference to the solvent signals. Mass spectra were measured on a Waters XEVO-TQD spectrometer or an Agilent 1290 UPLC/6540 Q-TOF spectrometer. Analytical or semi-preparative HPLC was performed on Agilent 1100 apparatus equipped with a UV detector and a SunFire OBD (Waters, 1.9 × 25 cm, 5 μm). Column chromatography was performed with silica gel (100--200 mesh and 200--300 mesh, Qingdao Yu-Min-Yuan Chemical Co. Ltd., Qingdao, P.R. China), MCI gel (CHP-20P, 70--150 μm, Mitsubishi Chemical Co., Japan) or Lichroprep RP-18 gel (40--63 mm, Merck, Darmstadt, Germany). Fractions were monitored by TLC (GF254, Qingdao Yu-Min-Yuan Chemical Co. Ltd., Qingdao, P.R. China), and the orange spots were visualized on the plate by spraying with 2% ninhydrin reagent, after hydrolyzed in an incubator (110 °C) for 30 min by concentrated HCl \[[@CR13]\].

Plant Material {#Sec5}
--------------

The roots and rhizomes of *C. lansium* were collected in Hekou, Yunnan Province, P. R. China, in September 2010, and identified by Prof. Yu-Min Shui, Kunming Institute of Botany, Chinese Academy of Sciences. A voucher specimen (No. 0599043) was deposited at the Herbarium of Kunming Institute of Botany, Chinese Academy of Sciences.

Extraction and Isolation {#Sec6}
------------------------

Air dried, powdered roots and rhizomes of *C. lansium* (27 kg) were extracted and refluxed with MeOH for three times each for 4 h (MeOH, 3\*50 L). The extract was evaporated under reduced pressure to yield a dark brown residue (0.9 kg). The residue was suspended in MeOH/H~2~O (7:3, 3 L) and then partitioned with EtOAc (3\*2 L). After removing solvent, the EtOAc-soluble part (406 g) was fractionated by silica gel (200--300 mesh) column chromatograph (CC) and eluted with CHCl~3~/MeOH (30:1--4:1) to afford six fractions (Fr.1--Fr.6), on the basis of TLC detection.

Fr.6 (77 g) was subjected to silica gel CC (CHCl~3~/acetone 15:1--7:3) to afford Fr.6.1--Fr.6.4. Fr.6.2 (14.3 g) was subjected to silica gel CC (PE/acetone 5:1), MPLC with MCI (MeOH/H~2~O 10:90--60:40), and MPLC with RP-18 (MeOH/H~2~O 5:95--70:30). Then, the fractions was further purified by silica gel CC (CHCl~3~/MeOH 50:1), subsequently to afford **1** (308 mg) and **2** (47 mg).

Clausenlanin A (**1**) {#Sec7}
----------------------

Amorphous powder; \[*α*\]~D~^20.7^ --154.6 (*c* 0.10, MeOH); UV (MeOH) λ~max~ (log *ε*) 203.0 (4.61) nm; CD (MeOH) 203 (Δ*ε*--30.8); IR (KBr) ν~max~ 3429, 2960, 1661, 1528, 584 cm^--1^; ^1^H (400 MHz) and ^13^C (100 MHz) NMR data, see Table [1](#Tab1){ref-type="table"}; positive ESIMSMS *m/z* 962.96 \[M+H\]^+^, 849.83 \[M+H−113\]^+^, 736.72 \[M+H−2\*113\]^+^, 623.64 \[M+H−3\*113\]^+^, 510.52 \[M+H−4\*113\]^+^, 453.49 \[M+H−4\*113−57\]^+^, 340.43 \[M+H−4\*113−57−113\]^+^, 227.29 \[M+H−4\*113−57−2\*113\]^+^; negative HRESIMS *m/z* 960.6876 \[M−H\]^−^, calcd for C~50~H~91~N~9~O~9~, 960.6867.

Clausenlanin B (**2**) {#Sec8}
----------------------

Amorphous powder; \[*α*\]~D~^20.6^ --73.69 (*c* 0.10, MeOH); UV (MeOH) λ~max~ (log *ε*) 202.8 (4.40) nm; CD (MeOH) 203 (Δ*ε*--26.1); IR (KBr) ν~max~ 3430, 2960, 1661, 1527, 584 cm^--1^; ^1^H (800 MHz) and ^13^C (200 MHz) NMR data, see Table [1](#Tab1){ref-type="table"}; positive ESIMSMS *m/z* 948.86 \[M+H\]^+^, 835.70 \[M+H−113\]^+^, 722.56 \[M+H−2\*113\]^+^, 609.54 \[M+H−3\*113\]^+^, 496.39 \[M+H−4\*113\]^+^, 383.41 \[M+H−5\*113\]^+^, 270.24 \[M+H−6\*113\]^+^; negative HRESIMS *m/z* 946.6723 \[M−H\]^−^, calcd for C~49~H~89~N~9~O~9~, 946.6710.

Advanced Marfey's Method \[[@CR11], [@CR12]\] {#Sec9}
---------------------------------------------

The cyclic peptide (about 1.0 mg each) was dissolved in 6 N HCl (1 mL) and heated at 110 °C for 24 h. The hydrolyzate was evaporated to dryness, and the residue was re-dissolved in 100 μL of acetone. To each a half portion (50 μL) were added 20 μL of NaHCO~3~ (1 M) and 100 μL of N^α^-(5-Fluoro-2,4-dinitrophenyl)-[l]{.smallcaps}-leucinamide ([l]{.smallcaps}-FDLA, 1% in acetone) or 50 μL of N^α^-(5-Fluoro-2,4-dinitrophenyl)-[l]{.smallcaps}-leucinamide and 50 μL of N^α^-(5-Fluoro-2,4-dinitrophenyl)-[d]{.smallcaps}-leucinamide (mixture of [l]{.smallcaps}-FDLA and [d]{.smallcaps}-FDLA, 1% in acetone), and the mixture was heated at 45 °C for 1.5 h. Reaction was cooled to room temperature, and then acidified with 2 N HCl (10 μL), dried and dissolved in 50% aqueous MeCN. 5 μL of each solution of FDLA derivatives were analyzed by LC/MS.

The analysis of the [l]{.smallcaps}- and [d]{.smallcaps}, [l]{.smallcaps}-FDLA (mixture of [d]{.smallcaps}- and [l]{.smallcaps}-FDLA) derivatives was performed using an Waters Sunfire C~18~ column (4.6\*150 mm, 5 μm) maintained at 30 °C. Acetonitrile---0.1% HCOOH/H~2~O was used as the mobile phase under a linear gradient elution mode (acetonitrile, 28--60%, 50 min (compound **1**); acetonitrile, 35--60%, 50 min (compound **2**)) at a flow rate of 1 mL/min. A Waters Xevo-TQD mass spectrometer was used for detection in ESI^−^ mode. The capillary voltage was kept at 2.5 kV, and the ion source at 450 °C. Nitrogen gas was used as a sheath gas at 650 L/h. A mass range of m/z 100--2000 was scanned in 0.2 s.
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